|
| ID |
DDInter1580 |
| Drug Type |
small molecule |
| Molecular Formula |
C21H19Brn4O2 |
| Molecular Weight |
439.313
|
| Description |
Remimazolam is an ultra short-acting benzodiazepine used for the induction and maintenence of procedural sedation during short procedures.
|
| ATC Classification |
N05CD14
|
| IUPAC Name |
Methyl 3-[(7S)-12-Bromo-3-Methyl-9-(Pyridin-2-Yl)-2,5,8-Triazatricyclo[8.4.0.0^{2,6}]Tetradeca-1(14),3,5,8,10,12-Hexaen-7-Yl]Pro |
| InChI |
Inchi=1S/C21H19Brn4O2/C1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21/H3-6,8,10-12,17H,7,9H2,1-2H3/T17-/M0/S1 |
| InChI Key |
CYHWMBVXXDIZNZ-KRWDZBQOSA-N |
| Canonical SMILES |
COC(=O)CC[C@@H]1N=C(C2=CC=CC=N2)C2=CC(Br)=CC=C2N2C(C)=CN=C12 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|